Oculis Holding AG Ordinary shares (OCS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $29.99
• Market Cap: $1.71B
• EPS: $-2.79
• 52-Week High: $30.68
• 52-Week Low: $14.00

Market Sentiment

Oculis Holding AG Ordinary shares currently has a Bullish sentiment score of 0.46.

About Oculis Holding AG Ordinary shares

Oculis Holding AG is an innovative biopharmaceutical company based in Zug, Switzerland, specializing in the development of groundbreaking topical therapies for a range of ophthalmic diseases affecting both the front and back of the eye. Leveraging advanced formulation technologies, Oculis aims to address significant unmet medical needs in vision care, focusing on enhancing patient outcomes through effective and user-friendly treatment options. With its robust pipeline, the company is position...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Oculis Holding AG Ordinary shares and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does OCS pay dividends?

Oculis Holding AG Ordinary shares (OCS) does not currently pay a regular dividend.

What is OCS's market cap?

Oculis Holding AG Ordinary shares (OCS) has a market capitalization of $1.71B with a current stock price of $29.99.